Dianthus Therapeutics, Inc. (DNTH) stock
DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$92.48+3.18 (+3.56%)
Close on Nov 12, 2026Market cap $5.17BP/E –Yield 0.00%
Dianthus Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Dianthus Therapeutics's enterprise value was $4.79B on Nov 11, 2026, against $1.83B a year earlier. Over the last 5 years it ranged from -$148.50M to $5.68B, with a median of $359.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.79B | +179.7% |
| 2025 | Dec 31, 2025 | $1.71B | +376.5% |
| 2024 | Dec 31, 2024 | $359.06M | – |
| 2023 | Dec 29, 2023 | -$35.77M | – |
| 2022 | Dec 30, 2022 | -$100.35M | – |
| 2021 | Dec 31, 2021 | -$132.21M | – |
| 2020 | Dec 31, 2020 | -$73.10M | – |
| 2019 | Dec 31, 2019 | -$21.37M | – |
| 2018 | Dec 31, 2018 | -$116.56M | – |
See a number that looks wrong?